The office might have had a few phone calls so kudos to Greg Collier for getting onto BRR asap to clear up any confusion the announcement had caused. Many CEOs wouldn't care to elaborate & say 'it is what it is!'.
Well, the future does sound better hearing it verbally from Greg reminding us there has been no Lupus drug for 50 years & proving the safety efficacy is a very important target for the FDA process to move forward here.
We'll get result updates from the other two over the next few months....we all hope our patience will be well rewarded in the end & have faith in this Board to lead us there.
BOLTAH - Katy
IVX Price at posting:
6.9¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)